BLND
Blend Labs, Inc.
BLND's outlook is improving, though it still trails on the overall score.
MSFT
Microsoft Corporation
MSFT has the edge over BLND overall, supported by lower modeled downside and stronger valuation.
BLND Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Unavailable |
BLND's cash flow is currently healthy, and its revenue is stable, but its profitability is under pressure. There isn't enough data to rate its balance sheet.
MSFT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.
BLND PE Valuation
BLND has no meaningful PE right now: it lost money over the past year.
MSFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $523 | — |
| Cheap | 27x | $525 | +0.4% |
| Current | 27x | $523 | — |
| Fair | 34x | $652 | +25% |
| Expensive | 37x | $711 | +36% |
Historical ranges are pointers, not guarantees.
MSFT's PE is in its cheap range at 27x. If earnings grow as analysts expect, today's price would be 25x next year's earnings.
BLND Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect BLND's earnings to grow and its profitability to improve, with its revenue holding steady.
MSFT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for MSFT, with profitability holding steady.
BLND Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.04 | — |
| Q3 2024 | -$0.33 | +$0.64 |
| Q2 2024 | -$0.48 | +$0.88 |
| Q1 2024 | -$0.57 | +$2.67 |
| Q4 2023 | -$0.76 | +$2.52 |
MSFT has the stronger earnings trend. Trailing diluted EPS is down 116% for BLND versus MSFT up 36%.
MSFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.79 | +8.6% |
| Q3 2026 | $19.15 | +36% |
| Q2 2026 | $17.95 | +32% |
| Q1 2026 | $16.80 | +30% |
| Q4 2025 | $15.99 | +29% |
| Q3 2025 | $14.06 | +16% |
| Q2 2025 | $13.64 | +16% |
| Q1 2025 | $12.93 | +12% |
| Q4 2024 | $12.41 | +12% |
MSFT's earnings per share have climbed steadily: $19.15 over the past year, up 36% from the year before, and higher year over year for 14 quarters in a row.
BLND Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $32.9M | +0.2% |
| Q2 2026 | $33.8M | +7.3% |
| Q1 2026 | $30.8M | +15% |
| Q4 2025 | $32.4M | -22% |
| Q3 2025 | $32.9M | -27% |
| Q2 2025 | $31.5M | -22% |
| Q1 2025 | $26.8M | -23% |
| Q4 2024 | $41.4M | +15% |
BLND's revenue fell from its 2021 peak and has held roughly level since: $33M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -8% | +6.9 points |
| Q2 2026 | -4.7% | +10 points |
| Q1 2026 | -16% | +12 points |
| Q4 2025 | -11% | -6.7 points |
| Q3 2025 | -15% | +15 points |
| Q2 2025 | -15% | +18 points |
| Q1 2025 | -29% | +32 points |
| Q4 2024 | -4.3% | +56 points |
BLND's operating margin was −8% last quarter, up 6.9 points from the same quarter a year ago.
MSFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $92.3B | +19% |
| Q2 2026 | $90B | +18% |
| Q1 2026 | $82.9B | +18% |
| Q4 2025 | $81.3B | +17% |
| Q3 2025 | $77.7B | +18% |
| Q2 2025 | $76.4B | +18% |
| Q1 2025 | $70.1B | +13% |
| Q4 2024 | $69.6B | +12% |
MSFT has the edge over BLND on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +0.9 points |
| Q2 2026 | 45% | +0.2 points |
| Q1 2026 | 46% | +0.7 points |
| Q4 2025 | 47% | +1.6 points |
| Q3 2025 | 49% | +2.3 points |
| Q2 2025 | 45% | +1.8 points |
| Q1 2025 | 46% | +1.1 points |
| Q4 2024 | 45% | +1.9 points |
MSFT has the edge over BLND on profitability, with a higher operating margin.
BLND Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $94K | +$5.9M |
| Q2 2026 | $7.1M | +$17.2M |
| Q1 2026 | $6.2M | -61% |
| Q4 2025 | -$21K | +$7.1M |
| Q3 2025 | -$5.8M | -$4.4M |
| Q2 2025 | -$10.1M | -$1.6M |
| Q1 2025 | $15.8M | +$21.6M |
| Q4 2024 | -$7.2M | +$13.6M |
BLND has the edge over MSFT on cash flow, with more consistent year-over-year improvement.
MSFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.6B | -27% |
| Q2 2026 | $19.6B | -23% |
| Q1 2026 | $15.8B | -22% |
| Q4 2025 | $5.9B | -9.3% |
| Q3 2025 | $25.7B | +33% |
| Q2 2025 | $25.6B | +9.6% |
| Q1 2025 | $20.3B | -3.2% |
| Q4 2024 | $6.5B | -29% |
MSFT's free cash flow has been positive every quarter for seven years: $60B over the past year, down 23% from the year before.
BLND Net Leverage
BLND's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MSFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
MSFT's net debt is less than a year of its operating earnings (EBITDA).
BLND Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.4 | Neutral |
| Stochastic | 19.4 | Oversold |
BLND's weekly RSI is 38 (neutral) and its Stochastic is 19 (oversold).
MSFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 68.0 | Neutral |
MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
BLND PE vs Technology Sector
BLND has no meaningful PE right now: it lost money over the past year.
MSFT PE vs Technology Sector
| Metric | MSFT | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 2% below |
| PE % | 16 | 35 | 19 pts below |
MSFT is trading at 27x earnings, in line with the Technology sector's median of 28x.
BLND Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.05 | 1.9% above |
| 20 week MA | $1.37 | 22% below |
| 50 week MA | $1.77 | 40% below |
| 100 week MA | $2.63 | 59% below |
| 200 week MA | $2.44 | 56% below |
BLND has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 56% below its 200-week average.
MSFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $524.7 | 0.3% below |
| 20 week MA | $484.8 | 7.9% above |
| 50 week MA | $446.9 | 17% above |
| 100 week MA | $453.8 | 15% above |
| 200 week MA | $411.5 | 27% above |
MSFT has the edge over BLND on trend strength, trading above more of its moving averages.
BLND Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $20.9 | $7.53 | -64% |
| 2022 | $7.53 | $1.22 | -84% |
| 2023 | $1.22 | $2.55 | +109% |
| 2024 | $2.55 | $4.29 | +68% |
| 2025 | $4.29 | $3.05 | -29% |
| 2026 YTD | $3.05 | $1.07 | -65% |
BLND's yearly returns have swung widely, from +109% in 2023 to −84% in 2022. It's down 65% so far in 2026.
MSFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $159.0 | $222.8 | +40% |
| 2021 | $222.8 | $334.7 | +50% |
| 2022 | $334.7 | $238.7 | -29% |
| 2023 | $238.7 | $376.0 | +58% |
| 2024 | $376.0 | $430.5 | +14% |
| 2025 | $430.5 | $487.7 | +13% |
| 2026 YTD | $487.7 | $523.0 | +7.2% |
MSFT has the edge over BLND on returns for 2026, with the stronger performance.